Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia Infections | 36 | 2024 | 196 | 7.310 |
Why?
|
| Bacterial Vaccines | 21 | 2024 | 125 | 6.310 |
Why?
|
| Chlamydia trachomatis | 21 | 2024 | 68 | 4.890 |
Why?
|
| Chlamydia | 14 | 2023 | 42 | 3.030 |
Why?
|
| Vibrio cholerae | 14 | 2021 | 98 | 2.100 |
Why?
|
| Dendritic Cells | 10 | 2021 | 113 | 1.920 |
Why?
|
| Antibodies, Bacterial | 11 | 2024 | 109 | 1.900 |
Why?
|
| Porins | 6 | 2019 | 19 | 1.850 |
Why?
|
| Chlamydia muridarum | 8 | 2021 | 104 | 1.630 |
Why?
|
| Mice | 38 | 2024 | 5913 | 1.260 |
Why?
|
| Antigens, Bacterial | 9 | 2024 | 132 | 1.130 |
Why?
|
| Th1 Cells | 11 | 2019 | 92 | 1.100 |
Why?
|
| Membrane Proteins | 4 | 2021 | 517 | 1.100 |
Why?
|
| Mice, Inbred C57BL | 23 | 2023 | 1609 | 1.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2017 | 52 | 1.070 |
Why?
|
| Bacterial Proteins | 5 | 2020 | 540 | 1.010 |
Why?
|
| Immunity, Mucosal | 7 | 2021 | 47 | 0.980 |
Why?
|
| Chlamydophila psittaci | 2 | 2021 | 2 | 0.980 |
Why?
|
| Animals | 46 | 2024 | 15081 | 0.960 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2024 | 12 | 0.950 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2024 | 57 | 0.920 |
Why?
|
| Psittacosis | 2 | 2021 | 2 | 0.840 |
Why?
|
| Chitosan | 1 | 2021 | 36 | 0.770 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 4 | 0.700 |
Why?
|
| MicroRNAs | 4 | 2021 | 426 | 0.680 |
Why?
|
| Vaccines, Subunit | 7 | 2023 | 30 | 0.630 |
Why?
|
| Interleukin-1beta | 2 | 2017 | 70 | 0.630 |
Why?
|
| Immunity, Innate | 3 | 2017 | 149 | 0.620 |
Why?
|
| Cholera Toxin | 3 | 2024 | 39 | 0.620 |
Why?
|
| Female | 35 | 2024 | 20969 | 0.610 |
Why?
|
| Cholera | 3 | 2011 | 70 | 0.600 |
Why?
|
| Antigen Presentation | 5 | 2017 | 54 | 0.590 |
Why?
|
| Adjuvants, Immunologic | 6 | 2017 | 107 | 0.590 |
Why?
|
| Nanoparticles | 1 | 2021 | 318 | 0.560 |
Why?
|
| Signal Transduction | 5 | 2020 | 1908 | 0.560 |
Why?
|
| Vaccines, Synthetic | 5 | 2010 | 72 | 0.460 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2024 | 62 | 0.410 |
Why?
|
| Immunologic Memory | 2 | 2011 | 38 | 0.400 |
Why?
|
| Vagina | 4 | 2023 | 81 | 0.400 |
Why?
|
| Drug Evaluation | 1 | 2011 | 9 | 0.390 |
Why?
|
| Trachoma | 1 | 2010 | 2 | 0.370 |
Why?
|
| Blindness | 1 | 2010 | 17 | 0.360 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1371 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 186 | 0.360 |
Why?
|
| Th2 Cells | 2 | 2020 | 58 | 0.350 |
Why?
|
| Immunoglobulin A | 3 | 2019 | 58 | 0.340 |
Why?
|
| Interferon-gamma | 4 | 2021 | 250 | 0.340 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2020 | 16 | 0.340 |
Why?
|
| Cholera Vaccines | 3 | 2007 | 18 | 0.320 |
Why?
|
| Drug Delivery Systems | 4 | 2007 | 202 | 0.320 |
Why?
|
| Genitalia | 2 | 2019 | 17 | 0.320 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 18 | 0.310 |
Why?
|
| Genetic Vectors | 5 | 2011 | 158 | 0.310 |
Why?
|
| Vaccination | 4 | 2021 | 288 | 0.310 |
Why?
|
| Vaginal Diseases | 1 | 2007 | 9 | 0.300 |
Why?
|
| Viral Vaccines | 2 | 2006 | 29 | 0.300 |
Why?
|
| Hela Cells | 6 | 2018 | 366 | 0.300 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 20 | 0.290 |
Why?
|
| Herpes Genitalis | 1 | 2006 | 6 | 0.290 |
Why?
|
| Herpesvirus 2, Human | 1 | 2006 | 9 | 0.290 |
Why?
|
| Immunity, Cellular | 4 | 2017 | 70 | 0.280 |
Why?
|
| NF-kappa B | 2 | 2020 | 339 | 0.270 |
Why?
|
| Viral Envelope Proteins | 1 | 2006 | 82 | 0.270 |
Why?
|
| Interleukin-10 | 5 | 2017 | 75 | 0.270 |
Why?
|
| Caspase 1 | 2 | 2017 | 15 | 0.270 |
Why?
|
| Humans | 22 | 2024 | 37093 | 0.260 |
Why?
|
| Vaccines, Combined | 3 | 2011 | 11 | 0.240 |
Why?
|
| Ruminants | 1 | 2023 | 7 | 0.230 |
Why?
|
| Epitopes | 1 | 2024 | 148 | 0.230 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 48 | 0.230 |
Why?
|
| Fertility | 3 | 2015 | 59 | 0.220 |
Why?
|
| Chickens | 2 | 2021 | 133 | 0.220 |
Why?
|
| Pelvic Inflammatory Disease | 2 | 2020 | 19 | 0.220 |
Why?
|
| Pregnancy | 4 | 2023 | 1549 | 0.220 |
Why?
|
| Administration, Intranasal | 2 | 2021 | 79 | 0.210 |
Why?
|
| Computer Simulation | 1 | 2024 | 362 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 197 | 0.190 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 626 | 0.190 |
Why?
|
| Genital Diseases, Female | 4 | 2007 | 37 | 0.190 |
Why?
|
| Avian Proteins | 1 | 2020 | 4 | 0.180 |
Why?
|
| Mice, Knockout | 10 | 2017 | 933 | 0.180 |
Why?
|
| Immunoglobulin G | 3 | 2013 | 237 | 0.180 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2020 | 27 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2009 | 88 | 0.180 |
Why?
|
| Lymphocyte Activation | 5 | 2014 | 236 | 0.180 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2019 | 5 | 0.170 |
Why?
|
| Infertility, Female | 2 | 2013 | 24 | 0.170 |
Why?
|
| Antibody Formation | 3 | 2011 | 74 | 0.170 |
Why?
|
| Spleen | 2 | 2010 | 199 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2017 | 1518 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 225 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2020 | 384 | 0.150 |
Why?
|
| Administration, Rectal | 1 | 2017 | 18 | 0.150 |
Why?
|
| Macrophages | 2 | 2020 | 439 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.150 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 218 | 0.150 |
Why?
|
| Cell Line | 5 | 2020 | 1354 | 0.150 |
Why?
|
| Fibrosis | 1 | 2017 | 159 | 0.140 |
Why?
|
| Vaccines, DNA | 3 | 2013 | 23 | 0.140 |
Why?
|
| Flow Cytometry | 1 | 2017 | 399 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 448 | 0.140 |
Why?
|
| Blotting, Western | 1 | 2017 | 859 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 194 | 0.130 |
Why?
|
| Cytokines | 4 | 2017 | 602 | 0.130 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 24 | 0.120 |
Why?
|
| Proteomics | 3 | 2017 | 325 | 0.120 |
Why?
|
| Gram-Negative Bacteria | 2 | 2004 | 22 | 0.120 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 61 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 539 | 0.110 |
Why?
|
| Mucous Membrane | 3 | 2008 | 34 | 0.110 |
Why?
|
| Bacteriophage lambda | 1 | 2013 | 12 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2015 | 305 | 0.110 |
Why?
|
| Chlamydiaceae Infections | 1 | 2012 | 3 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 357 | 0.110 |
Why?
|
| Receptors, Fc | 2 | 2003 | 7 | 0.110 |
Why?
|
| Calcitriol | 1 | 2012 | 31 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2013 | 207 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 69 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 103 | 0.100 |
Why?
|
| Cross Protection | 1 | 2011 | 4 | 0.100 |
Why?
|
| Virus Shedding | 1 | 2010 | 8 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2011 | 63 | 0.090 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 14 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 90 | 0.090 |
Why?
|
| Photoperiod | 2 | 2020 | 26 | 0.090 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2009 | 16 | 0.090 |
Why?
|
| Inclusion Bodies | 2 | 2020 | 33 | 0.090 |
Why?
|
| Trypanosomiasis, African | 1 | 2009 | 23 | 0.090 |
Why?
|
| Antigens, Protozoan | 1 | 2009 | 72 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1198 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2011 | 387 | 0.080 |
Why?
|
| Protozoan Vaccines | 2 | 2009 | 15 | 0.080 |
Why?
|
| Genomics | 1 | 2010 | 223 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 661 | 0.080 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2009 | 83 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 58 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2005 | 30 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2005 | 166 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2007 | 19 | 0.070 |
Why?
|
| Vero Cells | 1 | 2006 | 93 | 0.070 |
Why?
|
| Fibronectins | 2 | 2017 | 66 | 0.070 |
Why?
|
| Cadherins | 2 | 2017 | 90 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1015 | 0.070 |
Why?
|
| Inflammation | 2 | 2013 | 618 | 0.070 |
Why?
|
| Chemokines | 2 | 2003 | 97 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2017 | 444 | 0.060 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 24 | 0.060 |
Why?
|
| Fungal Vaccines | 1 | 2004 | 41 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 66 | 0.060 |
Why?
|
| Plasmids | 1 | 2004 | 246 | 0.060 |
Why?
|
| Antibodies | 1 | 2004 | 141 | 0.060 |
Why?
|
| Intestines | 1 | 2003 | 64 | 0.060 |
Why?
|
| Apoptosis | 3 | 2017 | 1398 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2003 | 176 | 0.060 |
Why?
|
| Chlamydophila | 1 | 2003 | 1 | 0.060 |
Why?
|
| Chlamydophila Infections | 1 | 2003 | 1 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 209 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 201 | 0.060 |
Why?
|
| Rabbits | 1 | 2003 | 283 | 0.060 |
Why?
|
| Uterus | 1 | 2023 | 55 | 0.060 |
Why?
|
| Diarrhea | 1 | 2003 | 89 | 0.050 |
Why?
|
| Antigens | 1 | 2003 | 56 | 0.050 |
Why?
|
| Cell Wall | 1 | 2003 | 53 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 70 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 185 | 0.050 |
Why?
|
| Pregnancy, Ectopic | 1 | 2020 | 14 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 381 | 0.050 |
Why?
|
| Poultry Diseases | 1 | 2020 | 6 | 0.050 |
Why?
|
| Endocytosis | 1 | 2020 | 113 | 0.040 |
Why?
|
| Myosin Type II | 1 | 2018 | 18 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 674 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 164 | 0.040 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 2 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 6 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 24 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 18 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 53 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 18 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 67 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2017 | 2 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 14 | 0.040 |
Why?
|
| Actins | 1 | 2017 | 148 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 52 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2017 | 23 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 132 | 0.040 |
Why?
|
| Collagen | 1 | 2017 | 172 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 293 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 893 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 677 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 22 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2015 | 4 | 0.030 |
Why?
|
| Thrombospondin 1 | 1 | 2015 | 23 | 0.030 |
Why?
|
| Genitalia, Female | 2 | 2007 | 26 | 0.030 |
Why?
|
| Caspases | 1 | 2015 | 147 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 90 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 409 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 132 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 513 | 0.030 |
Why?
|
| Bacteriophage phi X 174 | 2 | 2004 | 11 | 0.030 |
Why?
|
| Drug Design | 2 | 2006 | 162 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 356 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 864 | 0.030 |
Why?
|
| Weaning | 1 | 2013 | 15 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 487 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 2012 | 9 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1207 | 0.030 |
Why?
|
| Serpins | 1 | 2012 | 27 | 0.030 |
Why?
|
| Swine | 1 | 2013 | 184 | 0.030 |
Why?
|
| Calcium | 1 | 2015 | 480 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 18 | 0.030 |
Why?
|
| Nigeria | 1 | 2011 | 86 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 30 | 0.020 |
Why?
|
| Proteome | 1 | 2012 | 144 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 195 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 681 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 186 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 268 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2009 | 79 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 39 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 168 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 69 | 0.020 |
Why?
|
| Phylogeny | 1 | 2011 | 644 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2007 | 27 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2231 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2005 | 17 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 51 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 587 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 144 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 211 | 0.010 |
Why?
|
| Bacteriolysis | 1 | 2003 | 2 | 0.010 |
Why?
|
| Drug Administration Routes | 1 | 2003 | 14 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 2003 | 37 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 2003 | 72 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 92 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 134 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 11712 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 224 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2002 | 1 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2002 | 14 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2002 | 19 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 16 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2003 | 110 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 35 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 39 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 295 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 56 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 101 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 174 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4268 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 85 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 5363 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 708 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 6741 | 0.010 |
Why?
|
| Male | 2 | 2013 | 20025 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 10129 | 0.010 |
Why?
|